LifeMine
Business Services · Massachusetts, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
30 Acorn Park Dr, Cambridge, Massachuset...Phone Number
(617) 460-1701Website
www.lifeminetx.comRevenue
$33.5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
2
1
2
1
1
About LifeMine
LifeMine Therapeutics works to scale the genomic discovery of new drug modalities from eukaryotic microbes. Their genomically-enabled drug discovery engine is poised to deliver a pipeline of medicines that will conquer previously unconquerable human diseases. The business is based out of Massachusetts.Explore more
LifeMine Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is LifeMine your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if LifeMine has recently received funding, and reach out quickly before it becomes old news!
Check out if LifeMine is spiking on competitors!
Product Launch: Get notified when LifeMine launches new products
LifeMine, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on LifeMine recently announced quarterly report
Funding: Get notified immidiatlly once LifeMine has new funding data
Click to see if LifeMine had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at LifeMine
Website visits: Recent activity has been detected on your website
Recommended Actions
Reach out to Masked Content who joined LifeMine as Masked Content
Find 2 more new buyers
Compare Similar Companies to LifeMine
Compare insights from companies similar to LifeMine, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
LifeMine
$33.5M
51-200
Private
$285M
2016
GV
Gregory VerdineCo-founder, President & CEO & Chief Technology Officer & Director
Company Profile Activity
Activity Insights
LifeMine is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
LifeMine is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about LifeMine.
LifeMine financials insights
Gather financial insights about LifeMine, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2016
Private Equity
$5M
2017
Series A
$55M
2021
Series B
$50M
2022
Series C
$175M
LifeMine Tech Stack
A closer look at the technologies used by LifeMine
See more technologies
Most Recent Scoops
Open Position
Open Position
Person-Based
Facilities Relocation / Expansion
LifeMine is planning to move offices in August 2025. The move will impact approximately 12 employees at the existing office located at 30 Acorn Park Drive, Cambridge, MA.
Facilities Relocation/Expansion
Open Position
LifeMine News & Media
LifeMine Therapeutics Appoints Jennifer A. Jarrett to Board of Directors
CAMBRIDGE, Mass.--(BUSINESS WIRE)--LifeMine Therapeutics Inc., a biopharmaceutical company reinventing drug discovery by mining genetically-encoded small molecules (GEMs) from the biosphere, today announced the appointment of Jennifer Jarrett to its board of directors. Ms. Jarrett is an accomplished executive in the healthcare and technology industries with expertise spanning operations, capital markets, finance, corporate development and strategy. “LifeMine continues to attract stellar talentLifeMine Therapeutics Expands Management Team with Appointments of Martin Stahl, Ph.D., as Chief Scientific Officer and Louis Plamondon, Ph.D., as Executive Vice President and Head of CMC
CAMBRIDGE, Mass.--(BUSINESS WIRE)--LifeMine Therapeutics Inc., a biopharmaceutical company reinventing drug discovery by mining genetically-encoded small molecules (GEMs) from the biosphere, today announced the appointments of Martin Stahl, Ph.D., as chief scientific officer and Louis Plamondon, Ph.D., as executive vice president and head of CMC. Dr. Stahl, former global head of lead discovery at Roche, will also lead LifeMine’s operations at its European offices in Basel, Switzerland. “Martin200th company welcomed by Basel Area Business & Innovation
ST. NEOTS, UNITED KINGDOM, July 6, 2022 /EINPresswire.com/ -- Basel Area Business & Innovation, a non-profit agency dedicated to growing the dynamic and rich ecosystem in the Basel area, recently celebrated its 200th success story. The agency …
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding LifeMine
Sign Up For FreeTo access detailed company insights
LifeMine Therapeutics works to scale the genomic discovery of new drug modalities from eukaryotic microbes. Their genomically-enabled drug discovery engine is poised to deliver a pipeline of medicines that will conquer previously unconquerable human diseases. The business is based out of Massachusetts.... Read More
